Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Characterization of the developmental landscape of murine RORγt+ iNKT cells.

Klibi J, Li S, Amable L, Joseph C, Brunet S, Delord M, Parietti V, Jaubert J, Marie J, Karray S, Eberl G, Lucas B, Toubert A, Benlagha K.

Int Immunol. 2019 Sep 30. pii: dxz064. doi: 10.1093/intimm/dxz064. [Epub ahead of print]

PMID:
31565740
2.

TCR density in early iNKT cell precursors regulates agonist selection and subset differentiation in mice.

Joseph C, Klibi J, Amable L, Comba L, Cascioferro A, Delord M, Parietti V, Lenoir C, Latour S, Lucas B, Viret C, Toubert A, Benlagha K.

Eur J Immunol. 2019 Jun;49(6):894-910. doi: 10.1002/eji.201848010. Epub 2019 Apr 2.

PMID:
30912587
3.

Critical Contribution of NK Group 2 Member D Expressed on Invariant Natural Killer T Cells in Concanavalin A-Induced Liver Hepatitis in Mice.

Al Dulaimi D, Klibi J, Olivo Pimentel V, Parietti V, Allez M, Toubert A, Benlagha K.

Front Immunol. 2018 May 17;9:1052. doi: 10.3389/fimmu.2018.01052. eCollection 2018.

4.

Potential role of IL-17-producing iNKT cells in type 1 diabetes.

Li S, Joseph C, Becourt C, Klibi J, Luce S, Dubois-Laforgue D, Larger E, Boitard C, Benlagha K.

PLoS One. 2014 Apr 30;9(4):e96151. doi: 10.1371/journal.pone.0096151. eCollection 2014.

5.

Oligoclonal expansions of mucosal T cells in Crohn's disease predominate in NKG2D-expressing CD4 T cells.

Camus M, Esses S, Pariente B, Le Bourhis L, Douay C, Chardiny V, Mocan I, Benlagha K, Clave E, Toubert A, Mayer L, Allez M.

Mucosal Immunol. 2014 Mar;7(2):325-34. doi: 10.1038/mi.2013.51. Epub 2013 Aug 14.

PMID:
23945543
6.

Development and function of murine RORγt+ iNKT cells are under TGF-β signaling control.

Havenar-Daughton C, Li S, Benlagha K, Marie JC.

Blood. 2012 Apr 12;119(15):3486-94. doi: 10.1182/blood-2012-01-401604. Epub 2012 Feb 27.

PMID:
22371886
7.

Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy.

Ma Y, Aymeric L, Locher C, Mattarollo SR, Delahaye NF, Pereira P, Boucontet L, Apetoh L, Ghiringhelli F, Casares N, Lasarte JJ, Matsuzaki G, Ikuta K, Ryffel B, Benlagha K, Tesnière A, Ibrahim N, Déchanet-Merville J, Chaput N, Smyth MJ, Kroemer G, Zitvogel L.

J Exp Med. 2011 Mar 14;208(3):491-503. doi: 10.1084/jem.20100269. Epub 2011 Mar 7. Erratum in: J Exp Med. 2011 Apr 11:208(4):869.

8.

Cutting edge: crucial role of IL-1 and IL-23 in the innate IL-17 response of peripheral lymph node NK1.1- invariant NKT cells to bacteria.

Doisne JM, Soulard V, Bécourt C, Amniai L, Henrot P, Havenar-Daughton C, Blanchet C, Zitvogel L, Ryffel B, Cavaillon JM, Marie JC, Couillin I, Benlagha K.

J Immunol. 2011 Jan 15;186(2):662-6. doi: 10.4049/jimmunol.1002725. Epub 2010 Dec 17.

9.

Skin and peripheral lymph node invariant NKT cells are mainly retinoic acid receptor-related orphan receptor (gamma)t+ and respond preferentially under inflammatory conditions.

Doisne JM, Becourt C, Amniai L, Duarte N, Le Luduec JB, Eberl G, Benlagha K.

J Immunol. 2009 Aug 1;183(3):2142-9. doi: 10.4049/jimmunol.0901059. Epub 2009 Jul 8.

10.

iNKT cell development is orchestrated by different branches of TGF-beta signaling.

Doisne JM, Bartholin L, Yan KP, Garcia CN, Duarte N, Le Luduec JB, Vincent D, Cyprian F, Horvat B, Martel S, Rimokh R, Losson R, Benlagha K, Marie JC.

J Exp Med. 2009 Jun 8;206(6):1365-78. doi: 10.1084/jem.20090127. Epub 2009 May 18.

11.

Influence of a non-NK complex region of chromosome 6 on CD4+ invariant NK T cell homeostasis.

Vallois D, Gagnerault MC, Avner P, Rogner UC, Boitard C, Benlagha K, Herbelin A, Lepault F.

J Immunol. 2008 Aug 1;181(3):1753-9.

13.

Characterization of the early stages of thymic NKT cell development.

Benlagha K, Wei DG, Veiga J, Teyton L, Bendelac A.

J Exp Med. 2005 Aug 15;202(4):485-92. Epub 2005 Aug 8.

14.

Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors.

Egawa T, Eberl G, Taniuchi I, Benlagha K, Geissmann F, Hennighausen L, Bendelac A, Littman DR.

Immunity. 2005 Jun;22(6):705-16.

15.

Mechanisms governing B cell developmental defects in invariant chain-deficient mice.

Benlagha K, Park SH, Guinamard R, Forestier C, Karlsson L, Chang CH, Bendelac A.

J Immunol. 2004 Feb 15;172(4):2076-83.

16.

Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins.

Zhou D, Cantu C 3rd, Sagiv Y, Schrantz N, Kulkarni AB, Qi X, Mahuran DJ, Morales CR, Grabowski GA, Benlagha K, Savage P, Bendelac A, Teyton L.

Science. 2004 Jan 23;303(5657):523-7. Epub 2003 Dec 18.

17.

T cell development in mice expressing CD1d directed by a classical MHC class II promoter.

Forestier C, Park SH, Wei D, Benlagha K, Teyton L, Bendelac A.

J Immunol. 2003 Oct 15;171(8):4096-104.

18.

TGF-beta1 modulates Fas (APO-1/CD95)-mediated apoptosis of human pre-B cell lines.

Lanvin O, Guglielmi P, Fuentes V, Gouilleux-Gruart V, Mazière C, Bissac E, Regnier A, Benlagha K, Gouilleux F, Lassoued K.

Eur J Immunol. 2003 May;33(5):1372-81.

19.
20.

Thymocyte expression of cathepsin L is essential for NKT cell development.

Honey K, Benlagha K, Beers C, Forbush K, Teyton L, Kleijmeer MJ, Rudensky AY, Bendelac A.

Nat Immunol. 2002 Nov;3(11):1069-74. Epub 2002 Oct 7.

PMID:
12368909
21.

Testing the NKT cell hypothesis of human IDDM pathogenesis.

Lee PT, Putnam A, Benlagha K, Teyton L, Gottlieb PA, Bendelac A.

J Clin Invest. 2002 Sep;110(6):793-800.

22.

A thymic precursor to the NK T cell lineage.

Benlagha K, Kyin T, Beavis A, Teyton L, Bendelac A.

Science. 2002 Apr 19;296(5567):553-5.

23.

Distinct functional lineages of human V(alpha)24 natural killer T cells.

Lee PT, Benlagha K, Teyton L, Bendelac A.

J Exp Med. 2002 Mar 4;195(5):637-41.

24.

CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain.

Jayawardena-Wolf J, Benlagha K, Chiu YH, Mehr R, Bendelac A.

Immunity. 2001 Dec;15(6):897-908.

25.

Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d.

Chiu YH, Park SH, Benlagha K, Forestier C, Jayawardena-Wolf J, Savage PB, Teyton L, Bendelac A.

Nat Immunol. 2002 Jan;3(1):55-60. Epub 2001 Dec 3.

PMID:
11731798
26.

The mouse CD1d-restricted repertoire is dominated by a few autoreactive T cell receptor families.

Park SH, Weiss A, Benlagha K, Kyin T, Teyton L, Bendelac A.

J Exp Med. 2001 Apr 16;193(8):893-904.

27.

CD1d-restricted mouse V alpha 14 and human V alpha 24 T cells: lymphocytes of innate immunity.

Benlagha K, Bendelac A.

Semin Immunol. 2000 Dec;12(6):537-42. Review.

PMID:
11145859
28.

In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers.

Benlagha K, Weiss A, Beavis A, Teyton L, Bendelac A.

J Exp Med. 2000 Jun 5;191(11):1895-903.

29.

Unaltered phenotype, tissue distribution and function of Valpha14(+) NKT cells in germ-free mice.

Park SH, Benlagha K, Lee D, Balish E, Bendelac A.

Eur J Immunol. 2000 Feb;30(2):620-5.

30.

Modifications of Igalpha and Igbeta expression as a function of B lineage differentiation.

Benlagha K, Guglielmi P, Cooper MD, Lassoued K.

J Biol Chem. 1999 Jul 2;274(27):19389-96.

31.

[Analysis of expression of the molecules Igalpha and Igbeta in human pro-B leukemic lines].

Lassoued K, Guglielmi P, Benlagha K.

Bull Acad Natl Med. 1997 Oct;181(7):1465-75. French.

PMID:
9528188
32.

IL-7 sensitizes human pre-B cells but not pro-B cells to Fas/APO-1 (CD95)-mediated apoptosis.

Levy Y, Benlagha K, Buzyn A, Colombel M, Brouet JC, Lassoued K.

Clin Exp Immunol. 1997 Nov;110(2):329-35.

33.

Structural analysis of human antibodies to proteinase 3 from patients with Wegener granulomatosis.

Sibilia J, Benlagha K, Vanhille P, Ronco P, Brouet JC, Mariette X.

J Immunol. 1997 Jul 15;159(2):712-9.

PMID:
9218586
34.

Fate of surrogate light chains in B lineage cells.

Lassoued K, Illges H, Benlagha K, Cooper MD.

J Exp Med. 1996 Feb 1;183(2):421-9.

Supplemental Content

Loading ...
Support Center